MHELTHERA Presentations
Talks
2024
- Holger Stephan
Use photons to find tumours
6th International Caparica Conference on Chromogenic and Emissive Materials, Lisbon (Portugal), July 7 – 11, 2024
-
Michael Bachmann
Universal modular CARs: From the idea to the clinical application
TOLERATE: 2nd Progress Meeting, Antwerpen (Belgium), May 21-24, 2024
- Holger Stephan
The why and how of stealth nanoparticles
LIMNI Workshop: Advancing Healthcare Technologies, KU Leuven (Belgium), May 23, 2024
-
Michael Bachmann
Universal modular CARs: From the idea to the clinical application
Champalimaud’s “TIL (Tumor Infiltrating Lymphocytes) for the Treatment of Patients with Solid Cancer Experts on Future Perspectives” combined with Advanced Therapy Medicinal Products (ATMPs): Regulation and GMP Manufacturing Basics, Lisbon (Portugal), April 24-26, 2024
-
Jürgen Kogler
Development of multimodal FAPI-PET radiotracers for preoperative PET imaging and fluorescence-guided surgery
62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin (DGN), Leipzig (Germany), April 10-13, 2024
- Michael Bachmann
Combinatorial theranostic targeting of tumors and the tumor microenvironment
7th Theranostic World Congress, Santiago (Chile), March 22-24, 2024
- Anja Feldmann
Theranostic target molecules for adapter CAR-T cell therapies
26. Jahressymposium Interdisziplinäre Gruppe for Labor und Durchflusszytometrie (IGLD), Leipzig (Germany), March 7, 2024
- Michael Bachmann
UniCAR-basierte Therapie CD123-positiver Leukämien (TurbiCAR)
Netzwerkveranstaltung des BMBF für geförderte Projekte der „Innovationen für die individualisierte Medizin“ und der „Translationsprojekte Personalisierte Medizin“. dbb forum, Berlin (Germany), February 6-7, 2024
2023
-
Michael Bachmann
From Autoimmunity to adaptor CAR-T cells: Another “La”ve Story
Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation Regensburg (Germany), December 20, 2023
- Michael Bachmann
Gated Targeting: A long way from the idea to functionality
Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Leipzig (Germany), December 11, 2023
- Liliana Loureiro
Cancer immunotheranostics using adaptor CAR technologies and target modules
2023 HZDR Science Conference, Dresden (Germany), November 15 – 16, 2023
-
Christin Neuber
FAP-gerichtete Target Module für die Radionuklid-Theranostik und UniCAR T‑Zell-Therapie
Arbeitsgemeinschaft Radiochemie/Radiopharmazie, 1. Jahrestagung der GRPW e. V., Bad Salzuflen (Germany), September 28 – 30, 2023
-
Jürgen Kogler
Development of FAPI-PET Radiotracers for bimodal imaging and fluorescent-guided surgery
Arbeitsgemeinschaft Radiochemie/Radiopharmazie, 1. Jahrestagung der GRPW e. V., Bad Salzuflen (Germany), September 28 – 30, 2023
- Christin Neuber
FAP directed target modules for UniCAR T cell therapy and radionuclide-based tumour theranostics
European Association of Nuclear Medicine 2023, Vienna (Austria), September 09 – 13, 2023
- Larysa Baraban
Biodetection platforms based on the extended gate FETs
International Conference on Functional Nanomaterials and Nanodevices 2023, Warsaw (Poland), August 28 – 30, 2023
- Michael Bachmann
How to retarget immune cells for the treatment of cancer and infectious diseases: A 40-year journey from the idea to the clinic
Tumor immunology meets infectious diseases “TIMID”, Brandenburg (Germany), July 14, 2023
- Željko Janićijević
Biodetection platforms based on the extended gate FETs
Hengstberger Symposium on Bioelectronics: "mimicking and interfacing biological systems", Heidelberg (Germany), May 15 – 17, 2023
-
Michael Bachmann
Modular CARs
Tumor immunology meets oncology “TIMO 2023”, Halle (Germany), April 20-22, 2023
- Anja Feldmann
Wie Dresdner Forschende Immunzellen gegen Krebs nutzen
SaxoCell Lecture, Dresden (Germany), February 10, 2023
2022
- Claudia Arndt
Mildred-Scheel-Nachwuchszentrum Dresden: allogene UniCAR T-Zellen zur Behandlung und Therapieüberwachung der akuten myeloischen Leukämie35
Deutschen Krebskongress 2022 (DKK 2022), Berlin (Germany), November 15, 2022
- Kellie Tuck
Innovative sensing technologies – from lanthanide-based complexes to fluorescent labelled peptides
Seminar, HZDR, Dresden (Germany), November 11, 2022
- Holger Stephan
Bimodal Chelating Systems for Molecular Imaging
Seminar, Kitakyushu University, Kitakyushu (Japan), October 12, 2022;
Seminar, Saga University, Saga (Japan), October 19, 2022
- Holger Stephan
Multifunctional Stealth Nanoparticles for Biomedical Applications
Seminar, Sophia University Tokyo (Japan), October 7, 2022;
Seminar, Kyushu University, Fukuoka (Japan), October 19, 2022
Seminar, The University of Tokyo, Tokyo (Japan), November 1, 2022
- Claudia Arndt
Breaking new ground - How CAR technology can change the landscape of cancer theranostics
Seminar Series, Central Clinical School, Monash University, Melbourne (Australia), October 14, 2022
- Liliana Loureiro
Driving modular CARs through solid tumours and their microenvironment - a new era in cancer immunotherapy
Seminar Series, Central Clinical School, Monash University, Melbourne (Australia), October 14, 2022
- Manja Kubeil
Radiopharmaceutical evaluation of bifunctional chelators and bioconjugates for tumour imaging and therapy
Seminar, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne (Australia), October 10, 2022;
Webinar lecture, Monash Biomedical Imaging, Melbourne (Australia), October 12, 2022;
Seminar, University of Queensland, Brisbane (Australia), October 13, 2022
- Claudia Arndt (Plenary Lecture)
CAR Technology Meets Theranostics – A New Era of Immunotheranostics for Hematological and Solid Tumors
Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 06 – 07, 2022
- Liliana Loureiro
Immunotheranostic target modules suitable for imaging and navigation of UniCAR T-cells to strike FAP-expressing solid tumours and their microenvironment
Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 6 – 7, 2022
- Manja Kubeil
A novel bispidine-based chelator for radiopharmaceutical applications
Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 6 – 7, 2022
- Ina Kopp
177Lu- and 225Ac-labelling bispidine conjugates targeting neuroendocrine tumors
FG Nuclear Chemistry of the German Society of Chemistry, Annual Meeting 2022, Bergisch Gladbach (Germany), October 04 – 06, 2022
- Ina Kopp
177Lu-, 225Ac- and 111In-labelled nonadentate bispidine ligands: synthesis, radiolabeling experiments and stability assays
TERACHEM 2022, Convention Center Bressanone (Italy), September 14-17, 2022
- Christin Neuber
FAP directed target modules are suitable for imaging and targeted radionuclide therapy of FAP-expressing solid tumours and their microenvironment
5th GyMIC Molecular Imaging Symposium, Leipzig (Germany), September 15 – 16, 2022
- Anja Feldmann
Theranostic Antibody- and CAR-based Platform Technology for Therapy and Imaging
Antibody Technologies and Therapeutics Conference, Monash University Prato Centre, Italy, September 11 – 14, 2022
- Liliana Loureiro
Driving UniCARs to successful immunotherapy of solid tumors expressing fibroblast activation protein (FAP)
Antibody Technologies and Therapeutics Conference, Monash University Prato Centre (Italy), September 11 – 14, 2022
- Claudia Arndt
Engineered T-Cells for personalized cancer therapy
Precision Oncology Symposium, MSNZ, CRTD, Dresden (Germany), June 15, 2022
- Michael Bachmann (Chair and Lecturer)
Playing Boolean Algebra with CAR T cells: Why and How
International LIT Symposium “Synthetic Immunology / Synthetic Biology”, Regensburg (Germany) June 2022
- Michael Bachmann
Gated Targeting with CAR-T Cells
7th Lithuania International Hematology Oncology Colloquium, Kaunas (Lithuania), May 26, 2022
- Michael Bachmann (Chair and Lecturer)
INCREASING THE SAFETY OF CAR TECHNOLOGY: GATED TARGETING WITH MODULAR CARS
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
- Anja Feldmann
ADAPTOR UNICAR AND REVCAR PLATFORMS FOR FLEXIBLE, SWITCHABLE AND COMBINATORIAL TUMOR TARGETING
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
- Liliana Loureiro
AS SMALL AS IT CAN BE: SHORT PEPTIDE-DERIVED TARGET MOLECULES FOR REDIRECTION OF UNICAR T-CELLS AND IMAGING OF SSTR2-EXPRESSING CANCERS
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
Poster
2023
- Manja Kubeil
Bispidine - One chelator to bind lutetium-177 and actinium-225
25th International Symposium on Radiopharmaceutical Sciences (iSRS), Honolulu (Hawaii), May 22 – May 26, 2023
2022
- Claudia Arndt (3min ePoster Presentation)
UNICAR CAR T CELL THERANOTICS FOR DIAGNOSTIC IMAGING AND THERAPY OF PROSTATE CANCER
The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022
URL dieses Artikels
https://www.hzdr.de/db/Cms?pOid=67722